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This case of oligometastatic prostate cancer to the foot highlights the importance of: 1) metastasis
remaining high in the differential for unexplained malady, in the setting of a primary cancer, despite an
atypical presentation, and 2) comparing sequential imaging studies to baseline images, especially when
remote, because subtle ﬁndings can declare themselves over time.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Although prostate cancer metastasis to the axial skeleton is com-
mon, oligometastasis to the foot, especially as a solitary site, is rare.We
present the case of a gentleman with known non-metastatic prostate
cancer,who suffered an ankle/foot injurywith progressivelyworsening
disability who was then diagnosed with metastasis after 18 months.Case presentation
The patient is a 64 y/o gentleman with a history of high-risk
prostate cancer, cT4N0M0, treated with deﬁnitive radiotherapy and
2 years of hormone therapy (HT). Six years ago, in 2008, while in his
usual state of good health, he presented with acute urinary obstruc-
tion. Diagnostic work-up revealed a PSA of 47.5 ng/mL and a digital
rectal examination notable for a hardened and enlarged prostate
gland. Biopsyof the prostate demonstratedGleason4þ 5¼ 9disease.
Bone scan revealed degenerative disease bilaterally, but no evidence
of skeletalmetastatic disease (Fig.1A), and CTscans demonstrated no
metastatic disease. He was staged T4 owing to likely bladder neck
invasion. HT was initiated with leuprolide and bicalutamide.
His PSA after 1 month of HT was 4.9. The patient was then
treated with Image Modulated Radiation Therapy (IMRT) to theg 121, Baltimore, MD 21287-
3.
Inc. This is an open access article upelvis and prostate (4556 cGy, 1/8/09e2/10/09), followed by IMRT
to the prostate only (3000 cGy, 2/11/09e3/3/09). Bicalutamide
was then discontinued and he continued with 2 years of HT with
leuprolide. After 6 months his PSA decreased to 0.2 and thereafter
was undetectable until 12/2011 when his PSA became detectable
at 0.3.
In 12/2012 his PSA rose to 1.0 and then on 6/17/2013 it
demonstrated an increase to 4.4. During the same month, he
twisted and sprained his ankle while playing golf. He was able to
ambulate and did not seek immediate medical attention. On 7/12/
2013, while having continued discomfort in the left ankle and foot,
a re-staging bone scan showed increased focal radiotracer uptake in
the left ankle and tarsometatarsal joints compatible with his 1-
month history of trauma (Fig. 1B). There was no evidence of
osseous metastatic disease. The swelling increased in his left leg,
ankle and foot. In August 2013 his primary medical doctor (PMD)
diagnosed a deep vein thrombosis (DVT), for which he was treated
with 6 months of warfarin.
In December 2013, his PSA increased to 16 and therapy was
initiated with peripheral androgen blockade (PAB) (ﬁnasteride
(5 mg daily) and bicalutamide (50 mg daily)). A re-staging bone
scan again showed increased radiotracer uptake in the left foot and
ankle, consistent with his recent injury. There was no evidence of
other skeletal metastases. The CT scan showed no evidence of
adenopathy. The PSA decreased to 5.57 in April 2014 e the PAB was
continued and in June 2014 when the PSA decreased to 3.2 the PAB
was interrupted. Then in June 2014, the PSA increased to 11, and the
PAB was restarted.nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Bone scans demonstrating navicular necrosis. (A) Baseline (October 2008), whole body bone scan, delayed-phase anterior projections following intravenous 26.3 mCi
Tc99 m, demonstrated “no evidence of skeletal metastatic disease”. Note the subtle radiotracer uptake in left tarsal region (blue arrows). (B) Follow-up (July 2013, 1 month after foot
trauma), whole body bone scan, 3-hour delay planar bone images in anterior and posterior projections following intravenous 26.6 mCi Tc-99m, demonstrated “no evidence of
osseous metastatic disease; left tarsometatarsal joint focal increased radiotracer uptake correlated with 1-month history of ankle sprain” (blue arrows).
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as well as swelling with ambulation. His PMD ruled out a DVT, pre-
scribed a supportive boot, and referred him to a foot and ankle sur-
geon. The subsequent MRI (Fig. 2) showed navicular fragmentationFigure 2. Contrast enhanced magnetic resonance imaging of left foot navicular bone, 14-m
(B), and axial view (C), demonstrated a “fragmented navicular bone, with 0.5 cm focus of n
with enhancement on post contrast. Imaging features more suggestive of infection rather twithmultiple fracture lines anda complex talonavicular joint effusion
containing blood products and marked synovitis, in addition to
extensive adjacent soft tissue and bone marrow edema with mild
heterogenous enhancement of the navicular. The features wereonths post foot/ankle trauma; sagittal view (A), fat saturated images in sagittal view
onviable bone; continued abnormal signal within the remaining fragmented navicular,
han osteonecrosis. Tumor considered unlikely” (yellow arrows).
Figure 3. Cytology specimen of navicular bone stained for H&E (A), demonstrating prostate-speciﬁc antigen (B), prostate-speciﬁc membrane antigen (C), and NKX3.1 protein
(D) positivity.
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chronic trauma, chronic avascular necrosis, and Charcot arthropathy.
Malignancywas considered an unlikely possibility. Also presentwere
tenosynovitis and a low-grade insertional partial tear of the posterior
tibial tendon, mild tendinosis of the insertion of the Achilles tendon,
and mild atrophy of the adductor minimi. A tagged white blood cell
(WBC) scan demonstrated no signiﬁcant WBC accumulation sugges-
tive of an infectious process. Radiographs of the foot and ankle in
September 2014 showed permeative, speckled radiolucent and radi-
odense changes in the navicular with irregular borders andmoderate
soft tissue swelling. The appearance was atypical for prostate
metastasis. The differential included chronic trauma, low-grade
infection, other neoplasm, vascular anomaly, or an unusual devascu-
larization of the bone. Meanwhile the patient’s PSA decreased to 5.2
while on the PAB. An LHRH agonist was added in October 2014,
initiating complete androgen blockade.
Because the etiology of the foot injury was not clear, in December
2014 the patient underwent a CT-guided biopsy of the navicular.
Bone biopsy and bone marrow aspirate samples were submitted for
culture and gram stain, all of which were negative. The cytology was
metastatic adenocarcinoma consistent with the prostatic primary.
Tumor cells were positive for PSA, PSMA and NKX3.1, which sup-
ported the diagnosis. (Fig. 3) The patient subsequently underwent a
successful navicular resection and reconstruction.Discussion
This patient had biochemical failure concurrent with trauma,
which suggests that the navicular injury was pathologic.
Although prostate cancer metastasis is common, oligometastasis
to the foot bones is rare.1e3 Prostate cancer metastasis in these
cases was low on the differential and the pathologic appearance
on imaging was atypical for prostate cancer metastasis.1,2 It is
possible that there was no underlying pathology in the navicular
prior to the trauma. Inﬂammation associated with the trauma
may have attracted circulating tumor cells and/or inﬂammatory
mediators could have triggered already present tumor cell
proliferation.4
In hindsight, upon close inspection of the past imaging, a small
focus of radiotracer uptake in the left tarsometatarsal joint is visible
on the initial screening bone scan (Fig. 1A). It remains plausible that
inﬂammatory factors from trauma may have provided medium for
the navicular metastasis in a feedback loop.
Conclusion
This report represents a rare case of prostate cancer with syn-
chronous, undiagnosed oligometastasis in the foot, with no other
metastases in a 6-year span.
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